Correlation of enthesitis indices with disease activity and function in axial and peripheral spondyloarthritis: a cross- sectional study comparing MASES, SPARCC and LEI

Imagem de Miniatura
Arquivos
art_PALOMINOS_Correlation_of_enthesitis_indices_with_disease_activity_and_2019.PDF (771.81 KB)
Citações na Scopus
20
Tipo de produção
article
Data de publicação
2019
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMC
Autores
PALOMINOS, Penelope Esther
CAMPOS, Ana Paula Beckhauser de
RIBEIRO, Sandra Lucia Euzebio
XAVIER, Ricardo Machado
XAVIER, Jady Wroblewski
OLIVEIRA, Felipe Borges de
GUERRA, Bruno
SALDANHA, Carla
MANCUSO, Aline Castello Branco
KOHEM, Charles Lubianca
Citação
ADVANCES IN RHEUMATOLOGY, v.59, article ID 23, 9p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: The presence of enthesitis is associated with higher disease activity, more disability and incapacity to work and a poorer quality of life in spondyloarthritis (SpA). There is currently no consensus on which clinical score should be used to assess enthesitis in SpA. The objective of the present work was to compare the correlation of three enthesitis indices (MASES, SPARCC and LEI) with measures of disease activity and function in a heterogeneous population of patients with axial and peripheral SpA. Methods: A cross-sectional study was conducted in three Brazilian public university hospitals; patients fulfilling ASAS classification criteria for peripheral or axial SpA were recruited and measures of disease activity and function were collected and correlated to three enthesitis indices: MASES, SPARCC and LEI using Spearman's Correlation index. ROC curves were used to determine if the the enthesitis indices were useful to discriminate patients with active disease from those with inactive disease. Results: Two hundred four patients were included, 71.1% (N = 145) fulfilled ASAS criteria for axial SpA and 28.9% (N = 59) for peripheral SpA. In axial SpA, MASES performed better than LEI (p = 0.018) and equal to SPARCC (p = 0.212) regarding correlation with disease activity (BASDAI) and function (BASFI). In peripheral SpA, only MASES had a weak but statistical significant correlation with DAS28-ESR (r(s) 0.310 p = 0.05) and MASES had better correlation with functional measures (HAQ) than SPARCC (p = 0.034). Conclusion: In this sample composed of SpA patients with high coexistence of axial and peripheral features, MASES showed statistical significant correlation with measures of disease activity and function in both axial and peripheral SpA.
Palavras-chave
Spondyloarthritis, Enthesitis, Disease activity, Function
URI
https://observatorio.fm.usp.br/handle/OPI/33239
Referências
  1. Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1
  2. Benegas M, 2012, J RHEUMATOL, V39, P2315, DOI 10.3899/jrheum.110687
  3. Benjamin M, 2009, ADV EXP MED BIOL, V649, P57
  4. Braun J, 2002, LANCET, V359, P1187, DOI 10.1016/S0140-6736(02)08215-6
  5. Bruce B, 2003, J RHEUMATOL, V30, P167
  6. CALIN A, 1994, J RHEUMATOL, V21, P2281
  7. Carneiro S, 2013, J RHEUMATOL, V40, P1719, DOI 10.3899/jrheum.121145
  8. Coates LC, 2013, ARTHRITIS RHEUM-US, V65, P1504, DOI 10.1002/art.37939
  9. da Costa IP, 2015, REV BRAS REUMATOL, V55, P48, DOI 10.1016/j.rbr.2014.05.005
  10. Dancey CP, 2004, STAT MATH PSYCHOL
  11. DAWES PT, 1987, ANN RHEUM DIS, V46, P717, DOI 10.1136/ard.46.9.717-a
  12. DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
  13. GARRETT S, 1994, J RHEUMATOL, V21, P2286
  14. Gladman DD, 2007, J RHEUMATOL, V34, P1167
  15. Gladman DD, 2004, J RHEUMATOL, V31, P1126
  16. Gorman JD, 2002, NEW ENGL J MED, V346, P1349, DOI 10.1056/NEJMoa012664
  17. Healy PJ, 2008, ARTHRIT RHEUM-ARTHR, V59, P686, DOI 10.1002/art.23568
  18. Kaya T, 2007, RHEUMATOL INT, V27, P323, DOI 10.1007/s00296-006-0218-0
  19. Laatiris A, 2012, RHEUMATOL INT, V32, P723, DOI 10.1007/s00296-010-1658-0
  20. Maksymowych WP, 2009, ANN RHEUM DIS, V68, P948, DOI 10.1136/ard.2007.084244
  21. MANDER M, 1987, ANN RHEUM DIS, V46, P197, DOI 10.1136/ard.46.3.197
  22. Mease PJ, 2014, J RHEUMATOL, V41, P1249, DOI 10.3899/jrheum.140182
  23. Mease PJ, 2011, ARTHRIT CARE RES, V63, pS64, DOI 10.1002/acr.20577
  24. PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107
  25. Rezvani A, 2014, MOD RHEUMATOL, V24, P651, DOI 10.3109/14397595.2013.850182
  26. Roussou E, 2012, CLIN EXP RHEUMATOL, V30, pS24
  27. Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645
  28. Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233
  29. Sivas F, 2009, CLIN RHEUMATOL, V28, P259, DOI 10.1007/s10067-008-1027-5
  30. Sudo-Szopiska I, 2015, ETIOPATHOGENESIS ULT, V15, P72, DOI [10.15557/JoU.2015.0006, DOI 10.15557/JOU.2015.0006]
  31. Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972
  32. Turan Y, 2009, JOINT BONE SPINE, V76, P642, DOI 10.1016/j.jbspin.2009.03.005
  33. Van der Heidje D, 1999, ANN RHEUM DIS, V26, P951
  34. van der Heijde D, 2009, ANN RHEUM DIS, V68, P1811, DOI 10.1136/ard.2008.100826
  35. van der Heijde D, 2013, RHEUMATOLOGY, V52, P321, DOI 10.1093/rheumatology/kes251
  36. van Tubergen A, 2003, ANN RHEUM DIS, V62, P140, DOI 10.1136/ard.62.2.140
  37. WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/17